Retaspimycin Hydrochloride

CAS No.

857402-63-2

MDL No.

N/A

C₃₁H₄₆ClN₃O₈

624.20

InChI Key

OIRUWDYJGMHDHJ-AFXVCOSJSA-N

Pack Size	Purity	Price	Availability
1 mg	95.77%	$285	In Stock
5 mg	95.77%	$532	In Stock
10 mg	95.77%	$808	In Stock
50 mg	95.77%	$2186	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

95.77%

$285

In Stock

5 mg

95.77%

$532

In Stock

10 mg

95.77%

$808

In Stock

50 mg

95.77%

$2186

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

Retaspimycin hydrochloride is the monohydrochloride salt of retaspimycin, a semi-synthetic, water-soluble analog of geldanamycin used in cancer treatment. It functions as an Hsp90 inhibitor and antineoplastic agent, containing retaspimycin(1+).

CAS No.	857402-63-2
Product Name	Retaspimycin Hydrochloride

Biological Targets

HSP90AA1·HSP90AB1

Associated Conditions

metastatic melanoma·non-small cell lung carcinoma·lung cancer·prostate carcinoma·breast carcinoma·

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Retaspimycin Hydrochloride

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

A phase I study of the HSP90 inhibitor retaspimycin hydrochloride (IPI-504) in patients with gastrointestinal stromal tumors or soft-tissue sarcomas.

Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.

Effect of a single administration of testosterone on the immune response and lymphoid tissues in mice.

Documentation

Similar Products

Retaspimycin